Critsal Respule: Your Premier PCD Pharma Franchise in Respiratory Care

About Levosalbutamol 1.25 mg: A Fast-Acting Bronchodilator for Breathing Relief

Tapping into the High-Demand Market of Asthma and COPD

Why Critsal Respule is a High-Profit Opportunity for Distributors

Partnering for Success with a Quality-Assured Product
Join Our Pharma Franchise for Unmatched Business Support

Home/Products /levosalbutamol-1-25-mg-respules

About the Product

Description


Critsal Respule is an essential bronchodilator medication containing Levosalbutamol 1.25 mg, formulated as a solution for nebulization. As a potent beta-2 agonist, it works by relaxing the smooth muscles of the airways, rapidly widening the air passages and significantly easing breathing. This makes it a crucial “rescue” medication for the treatment and prevention of bronchospasm associated with severe asthma, COPD, and other reversible obstructive airway diseases. The precise and effective delivery via a nebulizer ensures that the medication reaches the lungs directly, providing quick and reliable relief for patients experiencing acute respiratory distress.

The respiratory segment of the Indian pharmaceutical market is a high-volume, high-growth sector with a consistently high demand. The increasing prevalence of respiratory disorders due to rising air pollution, seasonal allergies, and other environmental factors ensures that products like Critsal Respule are a staple in both hospital and home-care settings. The continuous need for effective management of chronic and acute respiratory conditions makes this product a strategic choice for any distributor seeking a stable and profitable business. The market for this specific molecule is robust, with a constant prescription flow from specialists like pulmonologists and pediatricians.

We are dedicated to empowering our franchise partners with all the tools necessary for success. Our product, manufactured in a WHO-GMP certified facility, ensures impeccable quality, efficacy, and safety, which is crucial for building trust with healthcare professionals. We provide a complete promotional and marketing kit, including visual aids, product literature, and sample kits, to support your sales efforts. Our robust supply chain guarantees timely delivery and continuous stock availability, preventing any business interruptions. Partner with us to enter this stable and highly profitable market and establish a reputable and successful business as a key supplier of this top-quality respiratory medicine.

May include hoarseness, throat irritation, dry mouth, or cough. Long-term use can rarely lead to oral thrush (fungal infection). Rinse mouth after each use to prevent this.

Persistent asthma (mild to severe) Chronic obstructive pulmonary disease (COPD) Allergic and non-allergic airway inflammation Nebulization therapy in children and adults as prescribed

Use only with a nebulizer under medical supervision. Not for acute asthma attacks – use a rescue inhaler for quick relief. Rinse mouth after inhalation to prevent infections. Regular use is important for effectiveness – do not skip doses. Do not stop suddenly without consulting your doctor.

Store below 25°C. Protect from light and moisture. Do not freeze. Keep out of reach of children. Use immediately after opening the respule.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Levosalbutamol 1.25 mg Respules in the PCD pharma franchise market?

Levosalbutamol 1.25 mg Respules are used in nebulization therapy for bronchospasm, asthma, COPD, wheezing, and acute respiratory distress. It is a strong respiratory and hospital-care segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.

Why should medical distributors include this product in their range?

Medical distributors and wholesalers can benefit from steady demand in hospitals, emergency departments, ICUs, pediatric clinics, and respiratory care units. It is widely used for rapid relief in asthma and COPD attacks, ensuring consistent institutional and pharmacy sales.

Does Cafoli Lifecore offer PCD pharma franchise opportunities for this product?

Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for respiratory and nebulization formulations with monopoly rights, quality manufacturing standards, competitive pricing, and reliable supply support for distributors and medical agencies.

What benefits do wholesalers get by partnering for this respule product?

Wholesalers and medical agencies benefit from hospital procurement, ICU demand, emergency usage, chronic respiratory disease management, and repeat orders when partnering with Cafoli Lifecare.

How can I become a distributor or franchise partner for Levosalbutamol 1.25 mg Respules?

Medical distributors, stockists, wholesalers, and pharma professionals interested in this nebulization formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, pricing, product availability, and distribution support services.